Steven Duffy
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Toxicology top 1%
Papers in
-
- Meta-analysis and systematic reviews 6
- Co-authors
- Jos KleijnenSohan DeshpandeSteve RyderRobert WolffKate MissoShona LangPenny WhitingAdrían V. Hernández
- Journals
- Health Technology Assessment (15 papers)PharmacoEconomics (12 papers)Cochrane Database of Systematic Reviews (4 papers)International Journal of Technology Assessment in Health Care (4 papers)Journal of the Medical Library Association JMLA (3 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Steven Duffy
66 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pharmacology 1.4k
- Toxicology 159
- Family Practice 75
- Psychiatry and Mental health 447
- Pediatrics, Perinatology and Child Health 488
Countries citing papers authored by Steven Duffy
This map shows the geographic impact of Steven Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Duffy more than expected).
Fields of papers citing papers by Steven Duffy
This network shows the impact of papers produced by Steven Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Duffy. The network helps show where Steven Duffy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven Duffy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 14 | |
| 6 | 2020 | 4 | |
| 7 | 2018 | 11 | |
| 8 | 2017 | 30 | |
| 9 | 2017 | 5 | |
| 10 | 2016 | 13 | |
| 11 | Cannabinoids for Medical Use Hit paper breakdown → | 2015 | 1492 |
| 12 | 2015 | 63 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 6 | |
| 15 | 2013 | 24 | |
| 16 | 2009 | 88 | |
| 17 | 2008 | 94 | |
| 18 | 2006 | 103 | |
| 19 | 2002 | 75 | |
| 20 | 1999 | 7 |
About Steven Duffy
Steven Duffy is a scholar working on Family Practice, Statistics, Probability and Uncertainty, Health Informatics, Oncology and Psychiatry and Mental health, having authored 68 papers that have together received 3.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Meta-analysis and systematic reviews (6 papers), Advanced Breast Cancer Therapies (4 papers), Electroconvulsive Therapy Studies (3 papers), Health and Medical Research Impacts (3 papers), Economic and Financial Impacts of Cancer (3 papers), HER2/EGFR in Cancer Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Pharmacology (1.4k citations), Toxicology (159 citations), Family Practice (75 citations), Psychiatry and Mental health (447 citations) and Pediatrics, Perinatology and Child Health (488 citations). Steven Duffy has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Jos Kleijnen, Sohan Deshpande, Steve Ryder, Robert Wolff, Kate Misso, Shona Lang, Penny Whiting, Adrían V. Hernández, Marcello Di Nisio and J. Christiaan Keurentjes. Their work appears in journals such as Health Technology Assessment, PharmacoEconomics, Cochrane Database of Systematic Reviews, International Journal of Technology Assessment in Health Care and Journal of the Medical Library Association JMLA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.